Late Wednesday,German pharmaceutical CureVac announced what it called “sobering news about its experimental covid-19 vaccine candidate: In the interim results from a large clinical trial, the vaccine appeared to be only 47% effective. This latest disappointment is a reminder of how lucky the U.
S. has been to occupy…Read more...
Source: gizmodo.com